Nurix Therapeutics (NRIX) Operating Leases (2021 - 2026)
Nurix Therapeutics (NRIX) reported Operating Leases of $62.09 million for fiscal Q3 2026 (quarter ended Aug 31, 2026), up 17.8% from $52.7 million a year earlier and up 13.1% from the prior quarter.
Powered by 
Analysis
Nurix Therapeutics (NRIX) Operating Leases (2021 - 2026) Analysis & Trends
At the end of FY2025 (ended Nov 30, 2025), Nurix Therapeutics posted Operating Leases of $52.91 million, up 160.8% from FY2024.
- Operating Leases has a four-year compound annual growth rate of 54.9% (FY2021 to FY2025).
- By fiscal year, Operating Leases came in at $20.29 million in FY2024 (-12.3%), $23.13 million in FY2023 (+259.4%), $6.43 million in FY2022 (-30.0%) and $9.19 million in FY2021.
- The fiscal Q3 2026 figure ranks as the highest quarterly Operating Leases in data going back to fiscal Q4 2021.
- Year over year, Operating Leases has now increased in each of the last six quarters, with growth averaging 79.1% over the last eight quarters.
- The high point for year-over-year Operating Leases in five years was fiscal Q3 2024 (growth of 679.3%); the low point was fiscal Q3 2023 (a decline of 65.9%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $54.92 million (Q2 2026), $55.45 million (Q1 2026) and $52.91 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Nurix Therapeutics | 1.73 Bn | -891.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Aug 31, 2026 | 62.09 Mn |
| May 31, 2026 | 54.92 Mn |
| Feb 28, 2026 | 55.45 Mn |
| Nov 30, 2025 | 52.91 Mn |
| Aug 31, 2025 | 52.70 Mn |
| May 31, 2025 | 46.70 Mn |
| Feb 28, 2025 | 19.98 Mn |
| Nov 30, 2024 | 20.29 Mn |
| Aug 31, 2024 | 20.59 Mn |
| May 31, 2024 | 20.89 Mn |
| Feb 29, 2024 | 21.85 Mn |
| Nov 30, 2023 | 23.13 Mn |
| Aug 31, 2023 | 2.64 Mn |
| May 31, 2023 | 3.76 Mn |
| Feb 28, 2023 | 5.11 Mn |
| Nov 30, 2022 | 6.43 Mn |
| Aug 31, 2022 | 7.75 Mn |
| May 31, 2022 | 9.04 Mn |
| Feb 28, 2022 | 10.33 Mn |
| Nov 30, 2021 | 9.19 Mn |
API Access
Nurix Therapeutics Operating Leases API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-leases&ticker=NRIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-leases", "ticker": "NRIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-leases&ticker=NRIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();